OpenEvidence announces OncoKB integration with Memorial Sloan Kettering Cancer Center
OpenEvidence says it worked with Memorial Sloan Kettering Cancer Center to build OncoKB into its platform.
TLDR
On Oct. 22, 2026, OpenEvidence announced that it and Memorial Sloan Kettering Cancer Center had built OncoKB into OpenEvidence and said it was widening the tool’s reach. The company also said more than 85% of the center’s oncologists use OpenEvidence. Its post gave no measurement period or methodology for that figure and did not explain how oncologists access the integration.
Combined views
6.6K
4 Sources, first seen ago
